Back
Investors Title Vs. Neurogene Industry Stock Comparison
Buy
75
ITIC
Investors Title
Last Price:
272.46
Seasonality Move:
6.59%
Sell
5
NGNE
Neurogene
Last Price:
39.70
Seasonality Move:
50.43%
Buy
75
Investors Title (ITIC)
is a Buy
Is Investors Title a Buy, Sell or Hold?
- The current Investors Title [ITIC] share price is $273.04. The Score for ITIC is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ITIC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ITIC Stock Price Chart
What is Investors Title's stock price today?
-
The Investors Title share price today is $273.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITIC is experiencing slight selling pressure.
ITIC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.21 | Buy |
| Relative Strength Index (14 RSI): | 72 | Buy |
| Chaikin Money Flow: | -3488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (225.95 - 251.95) | Buy |
| Bollinger Bands (100): | (194.97 - 237.99) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.3 | Buy |
| Relative Strength Index (14 RSI): | 39.1 | Sell |
| Chaikin Money Flow: | -346626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.29 - 61.53) | Sell |
| Bollinger Bands (100): | (34.11 - 50.51) | Sell |
ITIC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 252.8 | Buy |
| 20-day SMA: | 241.78 | Buy |
| 50-day SMA: | 232.74 | Buy |
| 200-day SMA: | 189.55 | Buy |
| 8-day EMA: | 256.33 | Buy |
| 20-day EMA: | 244.97 | Buy |
| 50-day EMA: | 233.13 | Buy |
| 200-day EMA: | 198.93 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.39 | Sell |
| 20-day SMA: | 53.17 | Sell |
| 50-day SMA: | 46.66 | Sell |
| 200-day SMA: | 38.93 | Buy |
| 8-day EMA: | 54.03 | Sell |
| 20-day EMA: | 53.18 | Sell |
| 50-day EMA: | 48.36 | Sell |
| 200-day EMA: | 38.47 | Buy |
Investors Title Earnings Growth & ITIC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Investors Title Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||